DB00398 | Sorafenib | approved, investigational | yes | inhibitor | Details |
DB05190 | XL281 | investigational | unknown | | Details |
DB05984 | RAF-265 | investigational | unknown | | Details |
DB06999 | PLX-4720 | experimental | unknown | | Details |
DB07000 | N-{2,4-difluoro-3-[(5-pyridin-3-yl-1H-pyrrolo[2,3-b]pyridin-3-yl)carbonyl]phenyl}ethanesulfonamide | experimental | unknown | | Details |
DB08553 | (1E)-5-(1-piperidin-4-yl-3-pyridin-4-yl-1H-pyrazol-4-yl)-2,3-dihydro-1H-inden-1-one oxime | experimental | unknown | | Details |
DB08881 | Vemurafenib | approved | yes | inhibitor | Details |
DB08896 | Regorafenib | approved | yes | inhibitor | Details |
DB08912 | Dabrafenib | approved, investigational | yes | inhibitor | Details |
DB12010 | Fostamatinib | approved, investigational | unknown | inhibitor | Details |
DB11718 | Encorafenib | approved, investigational | yes | inhibitor | Details |
DB14840 | Ripretinib | approved | yes | inhibitor | Details |